tributyrin has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, SN; Lee, E; Lee, MK; Lim, SJ | 1 |
Basak, G; Czajka, A; Giermasz, A; Hoser, G; Jakóbisiak, M; Jalili, A; Lewandowski, S; Makowski, M; Marczak, M; Młynarczuk, I; Nowis, D; Stok osa, T | 1 |
2 other study(ies) available for tributyrin and B16 Melanoma
Article | Year |
---|---|
Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Growth Processes; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Emulsions; Histone Deacetylase Inhibitors; Injections, Intraperitoneal; Injections, Intravenous; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplastic Stem Cells; Particle Size; Polysorbates; Triglycerides; Tumor Cells, Cultured | 2011 |
Antitumor activity of tributyrin in murine melanoma model.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Butyric Acid; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Prodrugs; Time Factors; Triglycerides; Tumor Cells, Cultured | 2001 |